Top compounds associated with response to KCNH3


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.09
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.058 0.09
mRNA hyperforin CTRPv2 pan-cancer AAC 0.065 0.09
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC -0.056 0.09
mRNA Talazoparib GDSC1000 pan-cancer AAC -0.055 0.09
mRNA marinopyrrole A CTRPv2 pan-cancer AAC 0.074 0.1
mRNA CD-1530 CTRPv2 pan-cancer AAC 0.064 0.1
mRNA linifanib GDSC1000 pan-cancer AAC 0.057 0.1
mRNA BRD-K96970199 CTRPv2 pan-cancer AAC -0.12 0.1
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.1
Download CSV